Literature DB >> 1786632

Biology of pediatric peripheral neuroectodermal tumors.

C J Thiele1.   

Abstract

The pediatric peripheral neuroectodermal tumors which include neuroblastoma, peripheral neuroepithelioma and Ewing's sarcoma may correspond to distinct neural crest cell lineages or tumors arrested at different stages of neural crest development. Besides a brief commentary on the salient clinical features of these tumors, this review examines how cell and molecular biological studies have contributed to a re-classification of these tumors. The differentiation of these tumors is reviewed with a particular emphasis on retinoic acid induced differentiation of neuroblastoma as a model to identify genes important in controlling cell growth, suppression of tumorigenicity and induction of differentiation.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1786632     DOI： 10.1007/bf00554793

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


  32 in total

1.  Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.

Authors:  A Rosolen; L Whitesell; N Ikegaki; R H Kennett; L M Neckers
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

2.  Histogenesis of the human adrenal medulla. An evaluation of the ontogeny of chromaffin and nonchromaffin lineages.

Authors:  M J Cooper; G M Hutchins; M A Israel
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

3.  Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells.

Authors:  S A Bader; C Fasching; G M Brodeur; E J Stanbridge
Journal:  Cell Growth Differ       Date:  1991-05

4.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.

Authors:  P L Chen; P Scully; J Y Shew; J Y Wang; W H Lee
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

5.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

Authors:  V Ciccarone; B A Spengler; M B Meyers; J L Biedler; R A Ross
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

6.  Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.

Authors:  O M El-Badry; J A Romanus; L J Helman; M J Cooper; M M Rechler; M A Israel
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

7.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Neuroblastoma in adults. Three case reports and a review of the literature.

Authors:  J A Kaye; M J Warhol; C Kretschmar; L Landsberg; E Frei
Journal:  Cancer       Date:  1986-09-01       Impact factor: 6.860

9.  Familial neuroblastoma. Case reports, literature review, and etiologic considerations.

Authors:  B H Kushner; F Gilbert; L Helson
Journal:  Cancer       Date:  1986-05-01       Impact factor: 6.860

10.  Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma.

Authors:  C McKeon; C J Thiele; R A Ross; M Kwan; T J Triche; J S Miser; M A Israel
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701
View more
  15 in total

1.  Self-renewal capacity is a widespread property of various types of neural crest precursor cells.

Authors:  Andréa Trentin; Corinne Glavieux-Pardanaud; Nicole M Le Douarin; Elisabeth Dupin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

2.  Optimizing orthotopic cell transplantation in the mouse adrenal gland.

Authors:  Cibele C Cardoso; Stefan R Bornstein; Peter J Hornsby
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

3.  EWS-FLI-1 regulates the neuronal repressor gene REST, which controls Ewing sarcoma growth and vascular morphology.

Authors:  Zhichao Zhou; Ling Yu; Eugenie S Kleinerman
Journal:  Cancer       Date:  2014-01-10       Impact factor: 6.860

4.  Ewing sarcoma of the adrenal gland: a rare entity.

Authors:  Joseph-Vincent V Blas; Maxwell L Smith; Nabil Wasif; Curtiss B Cook; Richard T Schlinkert
Journal:  BMJ Case Rep       Date:  2013-07-13

5.  Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.

Authors:  Sandra Acosta; Cinzia Lavarino; Raquel Paris; Idoia Garcia; Carmen de Torres; Eva Rodríguez; Helena Beleta; Jaume Mora
Journal:  BMC Dev Biol       Date:  2009-02-12       Impact factor: 1.978

6.  The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells.

Authors:  Pietro Laneve; Lucia Di Marcotullio; Ubaldo Gioia; Micol E Fiori; Elisabetta Ferretti; Alberto Gulino; Irene Bozzoni; Elisa Caffarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

7.  Differential expression of beta 1, beta 3 and beta 4 integrins in sarcomas of the small, round, blue cell category.

Authors:  T Barth; P Möller; G Mechtersheimer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity.

Authors:  Andrej Lissat; Thomas Vraetz; Maria Tsokos; Ruth Klein; Matthias Braun; Nino Koutelia; Paul Fisch; Maria E Romero; Lauren Long; Peter Noellke; Crystal L Mackall; Charlotte M Niemeyer; Udo Kontny
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

9.  Extraskeletal Ewing's sarcoma in a great toe of a young boy.

Authors:  Tatiana Karine Simon Cypel; Benjamin Meilik; Ronald Melvin Zuker
Journal:  Can J Plast Surg       Date:  2007

10.  The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.

Authors:  Francesco Rugolo; Nicolas G Bazan; Jorgelina Calandria; Bokkyoo Jun; Giuseppe Raschellà; Gerry Melino; Massimiliano Agostini
Journal:  Oncogene       Date:  2021-07-31       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.